Merz Group Unveils New OTC Business Player for the New Year
Merz Group Unveils New OTC Business Player for the New Year At the turn of the year, Merz Lifecare and WindStar Medical completed their merger, resulting in the formation of…
Category News
Read MoreMerz Group Unveils New OTC Business Player for the New Year
Invests $150M in Patho Care via PathoCare Holdings, Hamershlag Private Capital
Invests $150M in Patho Care via PathoCare Holdings, Hamershlag Private Capital Hamershlag Private Capital Management Limited (HPCM), a prominent health technology investment firm, invests in Patho Care, LLC, a leading…
Analgesic from Xgene Pharmaceutical Reduces Pain and Opioid Use in Post-Surgical Trial
Analgesic from Xgene Pharmaceutical Reduces Pain and Opioid Use in Post-Surgical Trial Xgene Pharmaceutical has revealed further findings from a positive, multi-center, placebo-controlled, dose-ranging Phase 2b study (registration number: NCT06017999)…
Series E and E1 Warrant Exercises Secure $16.3 Million for Delcath Systems
Series E and E1 Warrant Exercises Secure $16.3 Million for Delcath Systems Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company dedicated to treating primary and metastatic liver cancers, announced…
CEL-SCI Prices $5 Million Public Offering
CEL-SCI Prices $5 Million Public Offering CEL-SCI Corporation (NYSE American: CVM), a clinical-stage immunotherapy company focused on cancer treatments, today announced the pricing of a public offering of 16,130,000 shares…
HCA Healthcare Appoints Wendy Warren as SVP & Chief Ethics Officer
HCA Healthcare Appoints Wendy Warren as SVP & Chief Ethics Officer HCA Healthcare, Inc. (NYSE: HCA), one of the nation’s leading healthcare providers, has announced the appointment of Wendy Warren…
Kerecis Expands Silicone Fish-Skin Line with SurgiClose®
Kerecis Expands Silicone Fish-Skin Line with SurgiClose® Kerecis, a leader in the use of sustainably sourced fish skin and fatty acids for cellular therapy, tissue regeneration, and protection, has announced…
Digital Health Tools Expanding to Support Patient Care, Reports IQVIA
Digital Health Tools Expanding to Support Patient Care, Reports IQVIA Despite a decline in venture funding for digital health companies over the past two and a half years, digital health…
Kidney disease: Proton Intelligence raises $6.95M for potassium monitoring trials
Kidney disease: Proton Intelligence raises $6.95M for potassium monitoring trials Proton Intelligence Inc., the developer of the innovative Continuous Potassium Monitoring (CKM™) platform, has successfully closed a $6.95 million USD…
Cardinal Health Begins Routine Actinium-225 Production at Theranostics Center
Cardinal Health (NYSE: CAH) has announced the initiation of weekly actinium-225 (Ac-225) production at its Center for Theranostics Advancement in Indianapolis, Indiana. This milestone follows a collaboration with TerraPower Isotopes…
HCA Healthcare Appoints Wendy Warren as SVP & Chief Ethics Officer
HCA Healthcare, Inc. (NYSE: HCA), a leading healthcare provider in the United States, has announced the appointment of Wendy Warren as senior vice president and chief ethics and compliance officer,…
FDA Approves Pfizer’s BRAFTOVI® for First-Line BRAF V600E-Mutant Colorectal Cancer
Pfizer Inc. (NYSE: PFE) has announced that the U.S. Food and Drug Administration (FDA) has granted approval for BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and mFOLFOX6 (fluorouracil,…